# Sermorelin FAQ: Common Questions Answered From the Research > Sermorelin FAQ: 22 common questions on safety, half-life, body composition, side effects, and comparisons, answered directly from the published research. Twenty-two common questions about sermorelin, answered straight from the literature and cited where the answer carries a number. ## What is sermorelin? Sermorelin (sermorelin acetate) is the amidated synthetic 29-amino-acid N-terminal fragment of growth hormone-releasing hormone — GHRH(1-29)NH2 / GRF(1-29), the shortest fragment that keeps full GHRH activity — and a pituitary growth-hormone secretagogue [3][14]. It prompts the pituitary to release the body's own growth hormone rather than supplying hormone from outside. ## What does sermorelin do to the body? It binds GHRH receptors on pituitary somatotrophs and stimulates the body's own pulsatile growth-hormone release, which raises liver-made IGF-1 [14]. Because it acts upstream, somatostatin and IGF-1 feedback stay intact, preserving the natural burst pattern of secretion rather than overriding it [4]. ## What is sermorelin used for? It was FDA-approved (as a now-withdrawn brand) for evaluating and treating growth-hormone deficiency and short stature in children [1]. In research it has since been studied for adult GH-axis aging, body composition, cognition, and sleep [6][9][13] — none of which is an approved indication. ## Does sermorelin work? For its historical approved use — accelerating growth in GH-deficient children — controlled trials showed it works, raising first-year height velocity from about 4.1 to roughly 7-8 cm/year [1]. For adult anti-aging and body-composition use, rigorous long-term efficacy data are limited, and authorities have cautioned the evidence is not yet established [5]. ## Is sermorelin safe? In its approved pediatric use and in short adult studies it was generally well tolerated, with mild transient injection-site reactions and an occasional transient hyperlipidemia that resolved [1][9]. Long-term adult-use data are limited, and a major editorial called GH-secretagogue anti-aging use "not yet ready for prime time" [5]. It is also prohibited in sport by WADA. ## What are the side effects of sermorelin? Reported effects in GHRH-analog studies include mild, transient injection-site reactions; an occasional transient hyperlipidemia that resolved [9]; and some impairment of glucose tolerance in elderly subjects on repeated dosing. In the 14-day older-men study, fasting glucose was unchanged [2]. Long-term adult-use data remain limited. ## How long does it take for sermorelin to work? Growth hormone is released within hours — a single dose elevates serum GH for roughly 3 hours [3]. But IGF-1 and body-composition endpoints in studies were measured over weeks to months, including 14-day and 16-week GHRH(1-29) regimens and a 20-week GHRH-analog trial [2][9][6]. ## What is sermorelin's half-life and how long does it stay in your system? GHRH(1-29) has a short plasma half-life on the order of about 10-12 minutes after intravenous dosing and is rapidly cleared, yet a single dose can keep serum GH elevated for roughly 3 hours [3]. Its brevity motivated longer-acting analogs like CJC-1295 and tesamorelin [11]. ## When is the best time to take sermorelin? Studies typically administered GHRH(1-29) at bedtime to coincide with the natural nocturnal GH pulse during slow-wave sleep [13]; the 20-week GHRH-analog trial also dosed before bedtime [6]. This describes research protocols built around endogenous timing — it is not a personal dosing recommendation. ## Is 3 months of sermorelin enough? Study durations varied widely — from 14 days to 16-20 weeks to 12-24 months in pediatric work [2][9][6][1] — so no single fixed course is defined by the literature. Outcomes were measured on a per-study basis, and reading any one timeline as a rule overreads the data. ## Does sermorelin burn fat? Research on GHRH-axis stimulation links pulsatile GH to lipolysis [7], and the stabilized analog tesamorelin significantly reduced visceral fat versus placebo in clinical trials [11]. Sermorelin-specific fat-loss outcomes in healthy adults are not established [9]. ## Is sermorelin effective for weight loss? No controlled trial shows sermorelin produces weight loss in healthy adults; the 16-week analog study found no body-weight change [9]. The body-composition evidence comes largely from the related analog tesamorelin in specific clinical populations [6][11] and from GH/IGF-1 physiology [7]. ## Does sermorelin build muscle? Sermorelin raises GH and IGF-1, the axis associated with lean-mass regulation [2], and reviews discuss GH/IGF-1 modulation against age-related decline [12]. Direct muscle-building outcomes for sermorelin in healthy adults are not demonstrated. ## Sermorelin before and after: what changes do studies report? In GH-deficient children, GHRH(1-29) raised first-year height velocity from about 4.1 to roughly 7-8 cm/year [1]; in older men, 14 days of twice-daily GHRH(1-29) restored GH and IGF-1 toward young-adult levels [2]. Adult cosmetic before/after claims outpace the controlled evidence, and the body-fat numbers belong to tesamorelin, not sermorelin [6]. ## How does sermorelin compare to CJC-1295? Both act at the GHRH receptor, but CJC-1295 carries stabilizing modifications (and, with DAC, albumin binding) that extend its half-life far beyond sermorelin's roughly 10-12 minutes [3]. Sermorelin gives a shorter, more physiologic GH pulse; CJC-1295 with DAC runs for days. ## Sermorelin vs ipamorelin: what is the difference? Sermorelin is a GHRH analog acting on the GHRH receptor; ipamorelin is a growth-hormone-releasing peptide acting on the ghrelin/GHS receptor — a different mechanism — so the two are often discussed as complementary secretagogues that reach GH release by separate pathways [14]. ## How does sermorelin differ from direct HGH injections? Direct HGH supplies exogenous growth hormone and overrides natural feedback, whereas sermorelin stimulates the pituitary to make its own GH, preserving pulsatile release and somatostatin/IGF-1 feedback — a more physiologic pattern [4]. ## Will sermorelin raise my IGF-1 levels? In older men, twice-daily GHRH(1-29) for 14 days produced dose-related increases in GH and IGF-1 [2], and a 16-week analog study raised IGF-1 and IGFBP-3 [9]. GHRH-axis stimulation generally raises IGF-1 within the physiologic range; in a 20-week analog trial IGF-1 rose 117% [6]. ## Does sermorelin affect testosterone? Sermorelin acts on the GH/IGF-1 axis rather than directly on testosterone; in men's-health research the two interact (testosterone can raise GH and IGF-1, and visceral fat shapes GHRH-stimulated GH release [10]), but sermorelin itself is not a testosterone therapy. ## Does sermorelin affect the brain? GHRH administration has been associated with effects on cognition in older adults in controlled studies of GHRH analogs [6], and the somatotropic axis interacts with brain function [12]. The mechanisms are still being characterized; the findings describe the drug class in research, not a treatment. ## Can sermorelin or GHRH improve cognition in older adults? A randomized, placebo-controlled trial of a GHRH analog in 152 older adults found a favorable effect on cognition (P=0.03) with IGF-1 up 117% within the physiologic range over 20 weeks [6]. These are research findings on the GHRH drug class, not a treatment claim for sermorelin. ## Does sermorelin actually help with sleep, or is it waking me up instead? GHRH has documented slow-wave-sleep-promoting effects in normal men, but those effects depend on the time of administration [13]; individual sleep responses vary, and the literature describes physiology rather than predicting any one person's experience [12]. --- A transit-board reading of the sermorelin literature — the GHRH(1-29) findings routed line by line, each GH and IGF-1 figure carried back to its study, the body-composition evidence marked as tesamorelin where it belongs, and the stop where the long-term adult data run out left openly unserviced; no clinic at this board and nothing here dosed, dispensed, or sold.